James Meyer, Senior Vice President and CFO of Thermo Fisher Scientific Inc. (NYSE:TMO), filed a Form 4 on August 24, 2026, disclosing a tax-related share disposition and updated beneficial ownership figures as of August 22, 2026.

Key Highlights

  • Shares disposed: 30.945 shares of Common Stock were disposed of on August 22, 2026, with transaction code F, at a price of $629.27 per share.
  • Direct ownership after transaction: Meyer beneficially owned 5,830.038 shares of Common Stock directly following the reported transaction.
  • Indirect ownership via 401(k): Meyer also held 58.37 shares indirectly through the TMO 401(k) plan.
  • Stock purchase plan shares: The direct holding includes 19.519 shares acquired under the issuer's employee stock purchase plan on May 15, 2026, according to the filing.
  • 401(k) accumulation period: Between March 1, 2026 and August 21, 2026, Meyer acquired 8.34 shares of TMO common stock under the TMO 401(k) plan.
  • Signatory: The form was signed by Melodie T. Morin as Attorney-in-Fact for James Meyer on August 24, 2026.

Thermo Fisher CFO's August 2026 Ownership Changes Detailed

According to the filing, James Meyer, who serves as Senior Vice President and Chief Financial Officer of Thermo Fisher Scientific Inc. (NYSE:TMO), reported a single non-derivative transaction on August 22, 2026. The transaction, coded "F," involved the disposal of 30.945 shares of Common Stock at $629.27 per share. Transaction code F typically denotes payment of exercise price or tax liability using shares, as defined by SEC instructions.

Following the reported transaction, the filing discloses that Meyer directly held 5,830.038 shares of Common Stock. The filing notes that this figure includes 19.519 shares acquired under the issuer's employee stock purchase plan on May 15, 2026. In addition to the direct holdings, the filing reports 58.37 shares held indirectly through the TMO 401(k) plan. The filing further states that between March 1, 2026 and August 21, 2026, Meyer acquired 8.34 shares of TMO common stock under that same 401(k) plan. No derivative securities transactions were reported in Table II of the filing.

The Form 4 was filed on August 24, 2026, with August 22, 2026 listed as the date of the earliest transaction. The form was submitted as an individual filing by one reporting person and was signed by Melodie T. Morin as Attorney-in-Fact for James Meyer.

What Was Disclosed

The filing reports a disposal of 30.945 Common Stock shares by Thermo Fisher Scientific's CFO at $629.27 per share, leaving direct beneficial ownership of 5,830.038 shares and indirect ownership of 58.37 shares via the TMO 401(k) plan.